Teacher Retirement System of Texas reduced its stake in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,934 shares of the medical equipment provider’s stock after selling 501 shares during the quarter. Teacher Retirement System of Texas’ holdings in Masimo were worth $2,799,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of MASI. National Bank of Canada FI lifted its position in Masimo by 195.6% in the third quarter. National Bank of Canada FI now owns 132,500 shares of the medical equipment provider’s stock worth $17,666,000 after purchasing an additional 87,675 shares during the period. Lecap Asset Management Ltd. acquired a new stake in shares of Masimo in the fourth quarter valued at $1,607,000. Nisa Investment Advisors LLC boosted its stake in Masimo by 16,740.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 5,052 shares of the medical equipment provider’s stock valued at $835,000 after buying an additional 5,022 shares in the last quarter. Trust Point Inc. bought a new stake in Masimo in the fourth quarter worth about $230,000. Finally, Barclays PLC boosted its position in shares of Masimo by 152.6% during the 3rd quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider’s stock valued at $5,329,000 after purchasing an additional 24,137 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.
Insider Activity
In other news, COO Bilal Muhsin sold 30,000 shares of Masimo stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the completion of the sale, the chief operating officer now directly owns 24,172 shares in the company, valued at $4,048,568.28. The trade was a 55.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Craig B. Reynolds sold 2,053 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the completion of the transaction, the director now owns 16,581 shares in the company, valued at $2,754,601.53. This represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on Masimo
Masimo Stock Up 1.2 %
NASDAQ:MASI opened at $169.70 on Wednesday. The business’s fifty day moving average price is $175.10 and its 200 day moving average price is $160.61. The firm has a market capitalization of $9.16 billion, a price-to-earnings ratio of 117.03 and a beta of 1.04. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $194.88.
Masimo (NASDAQ:MASI – Get Free Report) last issued its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.38. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The company had revenue of $600.70 million for the quarter, compared to the consensus estimate of $593.35 million. On average, sell-side analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.
About Masimo
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.
Featured Articles
- Five stocks we like better than Masimo
- The Basics of Support and Resistance
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What is the MACD Indicator and How to Use it in Your Trading
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Growth Stocks: What They Are, What They Are Not
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI – Free Report).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.